Posted in | News | Chemical Sensor

Ionfinity’s New Chemical Sensor for Security Industry

The U.S. Navy will provide an additional funding valued $786,000 to Ionfinity, a security technology company and a subsidiary of the alternate energy company VIASPACE, for a contract awarded earlier.

According to a notification received from the U.S. Navy by Ionfinity, the Navy has exercised an option for the provision of the funding for an extra duration of development for 18 months for which the company has received $492,000 as initial payment. So far, the total award received by Ionfinity under this Navy contract is $1,278,000.

The Small Business Technology Transfer (STTR) Program of the U.S. Navy had awarded the Miniature Electronic Sniffer for Navy Vertical Take off Unmanned Aerial Vehicles (VTUAVs) project to Ionfinity. In this project, the Jet Propulsion Laboratory of NASA, Sionex, Caltech, and Imaginative Technologies, VIASPACE and Ionfinity are collaborating on the development of small-sized, sensitive sniffer sensor.  

This sniffer sensor is in the form of a stand-alone and compact chemical detection gadget. The sensor incorporates a micro-gas chromatograph unit for better confirmation and detection capability, and a powerful detector that is known as the differential mobility spectrometer. The sensor has adopted a non-radioactive ionization technique that does not ionize multiply or fragment the specimens that are sampled. This gadget will able to detect particular chemicals at trace quantities as low as parts per billion in less than 5 s.

James Weiss, CEO at Ionfinity, explained that this sensor can be used for security industry, as well as commercial applications related to the medicine, agricultural, and environmental monitoring.

Source: http://www.viaspace.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.